The FDA removed semaglutide from its shortage list on February 21, 2025, and tirzepatide on December 19, 2024
What happens when your medication stops working Both tirzepatide and liraglutide can plateau
He said he expects the immense size of the growing market means there is plenty of room for the brand-name and generic competitors to compete
NICE recommends annual thyroid function testing in patients with type 1 diabetes (NG17) and considers it in type 2 diabetes when clinically indicated
Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor
Data extraction The generic and brand names of GLP-1 RAs approved by the FDA were used to identify adverse events of GLP-1 RAs in the DRUG files, including exenatide (BYETTA, BYDUREON), liraglutide (VICTOZA, SAXENDA), dulaglutide (TRULICITY), lixisenatide (ADLYXIN, SOLIQUA), and semaglutide (OZEMPIC, RYBELSUS, WEGOVY)